EP 4061808 A4 20231220 - COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
Title (en)
COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN, DIE DURCH DIE AKTIVIERUNG DES MUSKARINREZEPTORS GELINDERT WERDEN
Title (fr)
COMPOSITIONS ET MÉTHODES DE TRAITEMENT DE TROUBLES ATTÉNUÉS PAR ACTIVATION DU RÉCEPTEUR MUSCARINIQUE
Publication
Application
Priority
- US 201962936837 P 20191118
- US 202063030780 P 20200527
- US 2020060859 W 20201117
Abstract (en)
[origin: WO2021101875A1] Provided herein is a method of treating schizophrenia or a disease related to schizophrenia in a patient in need thereof. The method comprises orally administering to the patient twice daily an oral pharmaceutical composition comprising a plurality of xanomeline beads comprising xanomeline or a salt thereof, and plurality of trospium beads comprising a salt of trospium, via the titration scheme that comprises up-titration of the xanomeline, or a salt thereof, and the salt of trospium.
IPC 8 full level
A61K 9/16 (2006.01); A61K 31/4439 (2006.01); A61K 31/46 (2006.01); A61K 45/06 (2006.01); A61P 25/18 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01)
CPC (source: EP)
A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 31/4439 (2013.01); A61K 31/46 (2013.01); A61P 25/18 (2017.12)
C-Set (source: EP)
Citation (search report)
- [XAYI] US 2017095465 A1 20170406 - ELENKO ERIC [US], et al
- [YA] "ACNP 57Annual Meeting: Poster Session I", NEUROPSYCHOPHARMACOLOGY, SPRINGER INTERNATIONAL PUBLISHING, CHAM, vol. 43, no. Suppl 1, 1 December 2018 (2018-12-01), pages 77 - 227, XP037114788, ISSN: 0893-133X, [retrieved on 20181206], DOI: 10.1038/S41386-018-0266-7
- See references of WO 2021101875A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2021101875 A1 20210527; CA 3161952 A1 20210527; CN 115667235 A 20230131; EP 4061808 A1 20220928; EP 4061808 A4 20231220; JP 2023503056 A 20230126
DOCDB simple family (application)
US 2020060859 W 20201117; CA 3161952 A 20201117; CN 202080093687 A 20201117; EP 20888871 A 20201117; JP 2022529029 A 20201117